DENISE GARSHOTT: Open Payments
NPI 1730225707 · NORTHVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 64 payments from 21 companies in 2025. Trend: 2023 $877 · 2024 $1,211 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $237 |
| Lundbeck LLC | 10 | $235 |
| ABBVIE INC. | 12 | $166 |
| Neurocrine BioSciences, Inc. | 4 | $90 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Novo Nordisk Inc | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
Products named: REXULTI, AUSTEDO XR, VRAYLAR, INGREZZA, FANAPT, Auvelity, Wegovy, UZEDY.
Industry payments across MI — which companies pay providers there.
